SCHEMBL2769245

SCHEMBL2769245

COc1cc(F)c(N2CCC(=O)CC2)cc1F

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
FFAR4 Q5NUL3 1/20 0.49
ALDH1A1 P00352 5/20 0.46
KMT2A Q03164 1/20 0.46
ACACB O00763 1/20 0.42
SMN1; SMN2 Q16637 3/20 0.38
MAOB P27338 2/20 0.37
TSHR P16473 2/20 0.37
LMNA P02545 2/20 0.37
TP53 P04637 1/20 0.37
HSD17B10 Q99714 1/20 0.37
NR3C1 P04150 1/20 0.37
HTR7 P34969 2/20 0.36
PPOX P50336 1/20 0.36
MAPT P10636 2/20 0.36
NCOA1 Q15788 1/20 0.35
NCOA3 Q9Y6Q9 1/20 0.35
ALDH1A3 P47895 1/20 0.35
HTT P42858 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17542771 0.94 ALDH1A1 (0.46) FFAR4ALDH1A1KMT2AACACBSMN1; SMN2
SCHEMBL17893532 0.89 ALDH1A1 (0.43) FFAR4ALDH1A1KMT2ASMN1; SMN2MAOB
SCHEMBL17544205 0.83 ALDH1A1 (0.43) FFAR4ALDH1A1KMT2ASMN1; SMN2TSHR
SCHEMBL17543889 0.83 PPOX (0.54) ALDH1A1KMT2ASMN1; SMN2TSHRLMNA
SCHEMBL17543398 0.83 PDE4D (0.43) FFAR4ALDH1A1KMT2ALMNAHTR7
SCHEMBL2770309 0.80 FFAR4 (0.44) FFAR4ALDH1A1KMT2AACACBSMN1; SMN2
SCHEMBL31342675 0.80 ALDH1A1 (0.56) ALDH1A1KMT2ASMN1; SMN2LMNAMAPT
SCHEMBL2766363 0.79 HTR3E (0.54) FFAR4ALDH1A1LMNAHTR7MAPT
SCHEMBL30738817 0.79 CRBN (0.40) FFAR4ALDH1A1KMT2ANR3C1MAPT
SCHEMBL27179079 0.79 CRBN (0.40) FFAR4ALDH1A1KMT2ANR3C1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1627871-B1 CYCLIC AMINOPHENYL SULFAMATE DERIVATIVE ASKA PHARM CO LTD (JP) 2010-04-14 EP disclosed
US-7449466-B2 Cyclic aminophenyl sulfamate derivative ASKA PHARMACEUTICAL CO., LTD. (JP) 2008-11-11 US disclosed
US-20060189625-A1 Cyclic aminophenyl sulfamate derivative ASKA PHARMACEUTICAL CO., LTD. (JP) 2006-08-24 US disclosed
EP-1627871-A1 CYCLIC AMINOPHENYL SULFAMATE DERIVATIVE Teikoku Hormone Mfg. Co., Ltd. (JP) 2006-02-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060189625-A1 Cyclic aminophenyl sulfamate derivative SHBG, STS, ARSA FFAR4 2828/4885ALDH1A1 2953/4885KMT2A 1170/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.